Feature | Cath Lab | February 06, 2019

Edwards Lifesciences Recalls Swan-Ganz Catheters Due to Incorrect Assembly

The FDA has identified this as a Class I recall

Edwards Lifesciences Recalls Swan-Ganz hemodynamic catheters.

Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufactured Dec. 26, 2017, to April 19, 2018 due, to incorrect assembly that reversed the catheter lumens. This recall includes 1,426 devices in the United States.

If the lumens are reversed the clinician may note inaccurate pulmonary artery and central venous pressure values and waveforms. This may result in unintended treatment, which may result in adverse health consequences. The FDA recall notice stated the inaccurate waveforms and pressure values may also misguide a physician during placement of the catheter, increasing the risk of blood vessel perforation. This exposes the patient to a reasonable likelihood of a serious adverse health consequence or death, the FDA said.

These catheters provide a diagnostic tool for physicians to quickly measure blood pressures inside the veins, heart, and arteries and to measure blood flow and blood oxygen levels when used with a compatible cardiac output computer. These catheters are often used in patients who are undergoing complex surgery, such as open heart surgery, or require intensive, invasive monitoring to guide their care during serious illness. 

Lot numbers included in this recall are: 61321177, 61176373, 61227528, 61321254, 61176369, 61176314, 61176370, 61176367, 61176374, 61321241 and 61311580.

On Dec. 12, 2018, Edwards Lifesciences sent affected customers an “Urgent Recall Notification Letter” informing of affected model/lot numbers. The notice requested that customers return any unused units that are currently in their inventory with the affected model and lot numbers. Once returned, replacement product will be shipped to customers at no charge. Edwards Lifesciences pre-populated a “Customer Acknowledgement” form, attached to the notification, with the affected lots and requested that customers follow the instructions on the form to complete the recall process.

The company said there have not been any patient complications reported due to issues with the device. 

The company initiated a full recall Dec. 21, 2018.

Who to Contact for Information or Report Adverse Events

Customers with questions can contact Edward Lifesciences Technical Support Department at (800) 822-9837 option 1.

Healthcare professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Healthcare professionals employed by facilities that are subject to FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.

 

Related Content

IBM and Broad Institute Launch AI Initiative for Cardiovascular Disease Risk Prediction
News | Cardiac Diagnostics | February 15, 2019
IBM Watson Health and the Broad Institute of MIT and Harvard are launching a research partnership aimed at developing...
Nearly Half of All U.S. Adults Have Cardiovascular Disease
News | Cardiac Diagnostics | January 31, 2019
January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type
Frequent Red Meat Consumption Triples Levels of Chemical Associated With Heart Disease
News | Cardiac Diagnostics | January 23, 2019
Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical...
Plant-Based Diets Benefit Athletes' Heart Health, Endurance, Recovery
News | Cardiac Diagnostics | January 21, 2019
Meat-free athletes have already proven the performance-boosting power of a plant-based diet. Now, “Plant-Based Diets...
Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Overlay Init